Literature DB >> 16691503

Increased expression of peripheral benzodiazepine receptor (PBR) in dimethylbenz[a]anthracene-induced mammary tumors in rats.

Sutapa Mukhopadhyay1, Shyamali Mukherjee, Salil K Das.   

Abstract

Expression of peripheral benzodiazepine receptors (PBR) has been found in every tissue examined; however, it is most abundant in steroid-producing tissues. Although the primary function of PBR is the regulation of steroidogenesis, its existence in nonsteroidogenic tissues as well as in other cellular compartments including the nucleus suggests that there may be other roles for PBR. Our laboratory reported earlier a significant increase of PBR density in the nucleus of DMBA-induced malignant submandibular glands of rats, suggesting a role of PBR in nuclear events of peripheral tissues. Since then numerous studies have demonstrated the abundance of PBR in tumors. Numerous studies implicate a role for cholesterol in the mechanisms underlying cell proliferation and cancer progression. Based on studies with a battery of human breast cancer cell lines and several human tissue biopsies, Hardwick et al. suggested that PBR expression, nuclear localization, and PBR-mediated cholesterol transport into the nucleus are involved in human breast cancer cell proliferation and aggressive phenotype expression. The purpose of the present study is to confirm this hypothesis by developing an animal breast cancer model and correlating the above events with the breast cancer. Weanling rats were maintained on a diet containing animal protein (casein) for 30 days and then a single dose of DMBA in sesame oil (80 mg/kg) was administered by gavage to the animals. Control animals received the vehicle only. After 122 days of DMBA administration, the animals were sacrificed. All tumors were detected by palpation. B(max) of PBRs was 52.6% and 128.4% higher in the non-aggressive and aggressive cancer tissues, respectively, than that in normal tissues. Cholesterol uptake into isolated nuclei was found to be higher in both non-aggressive and aggressive tumor breast tissue than that in control tissue. There was also corresponding increase in B(max) of PBRs in the nucleus of cancer tissues. Furthermore, the nuclear nucleoside triphosphatase (NTPase) activity was found to be higher in aggressive tumor tissues than that in non-aggressive tumor tissues. In conclusion, these data suggest that PBR ligand binding, and PBR-mediated cholesterol transport into the nucleus may be involved in the development of mammary gland adenocarcinoma, thus participating in the advancement of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691503     DOI: 10.1007/s10719-006-7925-3

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  44 in total

1.  The nuclear membrane integrity assay.

Authors:  M P Czubryt; B Ramjiawan; G N Pierce
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

2.  Rapid semi-micro procedure for estimating free and total cholesterol.

Authors:  A J COURCHAINE; W H MILLER; D B STEIN
Journal:  Clin Chem       Date:  1959-12       Impact factor: 8.327

3.  Characterization of peripheral benzodiazepine binding sites in human term placenta.

Authors:  F Fares; M Gavish
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

4.  Specific binding of benzodiazepines to human breast cancer cell lines.

Authors:  A Beinlich; R Strohmeier; M Kaufmann; H Kuhl
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  Peripheral benzodiazepine stimulates secretion of growth hormone and mitochondrial proliferation in pituitary tumour GH3 cells.

Authors:  K L Black; T Shiraishi; K Ikezak; K Tabuchi; D P Becker
Journal:  Neurol Res       Date:  1994-04       Impact factor: 2.448

6.  Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells.

Authors:  G D Clarke; P J Ryan
Journal:  Nature       Date:  1980-09-11       Impact factor: 49.962

7.  The benzodiazepine receptor: its development and its modulation by gamma-aminobutyric acid.

Authors:  J W Regan; W R Roeske; H I Yamamura
Journal:  J Pharmacol Exp Ther       Date:  1980-01       Impact factor: 4.030

8.  Effects of dimethylbenz[a]anthracene-induced malignancy on the subcellular distribution of peripheral benzodiazepine receptors in submandibular glands of rats.

Authors:  S Mukherjee; A R Mohammad; S K Das
Journal:  Biochem Pharmacol       Date:  1990-10-01       Impact factor: 5.858

9.  Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries.

Authors:  Y Katz; G Ben-Baruch; Y Kloog; J Menczer; M Gavish
Journal:  Clin Sci (Lond)       Date:  1990-02       Impact factor: 6.124

10.  Benzodiazepines that bind at peripheral sites inhibit cell proliferation.

Authors:  J K Wang; J I Morgan; S Spector
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more
  3 in total

1.  TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.

Authors:  Yihui Chen; Munawwar Sajjad; Yanfang Wang; Carrie Batt; Hani A Nabi; Ravindra K Pandey
Journal:  ACS Med Chem Lett       Date:  2010-11-23       Impact factor: 4.345

2.  Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells.

Authors:  Sutapa Mukhopadhyay; Bobby Guillory; Shyamali Mukherjee; Salil K Das
Journal:  Mol Cell Biochem       Date:  2010-03-04       Impact factor: 3.396

3.  Differential Expressions of p53, p53R2, hRRM2 and PBR in Chronic Lymphocytic Leukemia: A Correlation with Intracellular Cholesterol.

Authors:  Ankit Verma; N C Chandra
Journal:  Indian J Clin Biochem       Date:  2015-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.